|
|
| | Myo-Inositol, cyclic 1,2:3,4:5,6-tris(P,P'-dihydrogen diphosphate) Basic information |
| Product Name: | Myo-Inositol, cyclic 1,2:3,4:5,6-tris(P,P'-dihydrogen diphosphate) | | Synonyms: | Myo-Inositol, cyclic 1,2:3,4:5,6-tris(P,P'-dihydrogen diphosphate);Myo-inositol 1,6:2,3:4,5 tripyrophosphate;Myo-Inositol Trispyrophosphate, sodiuM salt;Myo-inositol trispyrophosphate (ITPP);ITPP(Myo-Inositoltripyrophosphate);PubChem ID: 10439981;UNII-116EYZ0PPX;Myo-Inositol, Cyclic 1,2:3,4:5,6-Tris | | CAS: | 802590-64-3 | | MF: | C6H12O21P6 | | MW: | 605.99 | | EINECS: | 231-786-5 | | Product Categories: | | | Mol File: | 802590-64-3.mol |  |
| | Myo-Inositol, cyclic 1,2:3,4:5,6-tris(P,P'-dihydrogen diphosphate) Chemical Properties |
| Boiling point | 862.3±75.0 °C(Predicted) | | density | 2.41±0.1 g/cm3(Predicted) | | pka | 0.30±0.20(Predicted) | | InChIKey | UPSTXDBFJHPPGU-UUIWFVARNA-E |
| | Myo-Inositol, cyclic 1,2:3,4:5,6-tris(P,P'-dihydrogen diphosphate) Usage And Synthesis |
| Uses | myo-Inositol Trispyrophosphate is a hypoxia modifier in patients with hepatopancreatobiliary tumors. |
| | Myo-Inositol, cyclic 1,2:3,4:5,6-tris(P,P'-dihydrogen diphosphate) Preparation Products And Raw materials |
|